14-day Premium Trial Subscription Sign Up For FreeGet Free

Adamis Pharmaceuticals Corporation Stock Forecast NASDAQ:ADMP

Price Target and Analyst Ratings

Most Recent Rating

Maxim Group is very positive about ADMP and gave it a "Buy" rating on September 23, 2020. The price target was set to $1.50.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-01-22 Hold Reiterated by Maxim Group $1.79
2020-11-16 Buy - Hold Downgraded by Maxim Group $0.40
2020-09-23 Buy Reiterated by Maxim Group $0.74 $1.50
2020-08-19 Hold Reiterated by Raymond James $0.92
2020-06-16 Buy Reiterated by Maxim Group $0.62 $1.50
2020-06-15 Buy Upgraded by Dawson James $0.64 $1.00
2020-05-13 Hold - Buy Upgraded by Maxim Group $0.57 $1.50

ADMP Stock Trend

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected.

Given the current horizontal trend, you can expect Adamis Pharmaceuticals Corporation stock with a 90% probability to be traded between $0.92 and $1.24 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Data

Date Bottom Mid Top
2021-09-20 $0.92 $1.08 $1.24
2021-09-21 $0.92 $1.08 $1.24
2021-09-22 $0.92 $1.08 $1.24
2021-09-23 $0.92 $1.08 $1.24
2021-09-24 $0.92 $1.08 $1.24
2021-09-27 $0.92 $1.08 $1.24
2021-09-28 $0.92 $1.08 $1.24
2021-09-29 $0.92 $1.08 $1.24
2021-09-30 $0.92 $1.08 $1.24
2021-10-01 $0.92 $1.08 $1.24
2021-10-04 $0.92 $1.08 $1.24
2021-10-05 $0.92 $1.08 $1.24
2021-10-06 $0.92 $1.08 $1.24
2021-10-07 $0.92 $1.08 $1.24
2021-10-08 $0.92 $1.08 $1.24
2021-10-11 $0.92 $1.08 $1.24
2021-10-12 $0.92 $1.08 $1.24
2021-10-13 $0.92 $1.08 $1.24
2021-10-14 $0.92 $1.08 $1.24
2021-10-15 $0.92 $1.08 $1.24
2021-10-18 $0.92 $1.08 $1.24
2021-10-19 $0.92 $1.08 $1.24
2021-10-20 $0.92 $1.08 $1.24
2021-10-21 $0.92 $1.08 $1.24
2021-10-22 $0.92 $1.08 $1.24
2021-10-25 $0.92 $1.08 $1.24
2021-10-26 $0.92 $1.08 $1.24
2021-10-27 $0.92 $1.08 $1.24
2021-10-28 $0.92 $1.08 $1.24
2021-10-29 $0.92 $1.08 $1.24

About Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, engages in developing and commercializing products in the therapeutic areas of allergy and respiratory disease. Its specialty pharmaceutical product candidates include the Epinephrine Injection PFS syringe product for use in the emergency treatment of anaphylaxis; APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease; and APC-2000 for ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT